A Gene Therapy Study for Homozygous Familial Hypercholesterolemia (HoFH)
Stopped early · Phase 1/Phase 2
Conditions studied: Homozygous Familial Hypercholesterolemia (HoFH)
In brief
This first-in-human study is intended to evaluate the safety and preliminary effectiveness of AAV (Adeno-associated virus)-based liver-directed gene therapy in the treatment of adults with Homozygous Familial Hypercholesterolemia (HoFH).
Key facts
- Study ID
- NCT02651675
- Run by
- REGENXBIO Inc.
- People needed
- 9
- Starts
- 2016-03-01
- Expected to finish
- 2020-11-27
- Last updated by the study team
- 2023-07-13
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Male or female ≥ 18 years of age.
- Untreated and/or treated LDL-C levels and clinical presentation consistent with the diagnosis of homozygous FH (Familial hypercholesterolemia)
- Molecularly defined LDLR mutations at both LDLR alleles.
- A baseline serum AAV8 NAb (Neutralizing antibody) titer ≤ 1:10.
You may not qualify if…
- Unwilling to wash out of the following lipid lowering therapies for the pre-specified time period:
- niacin > 250 mg/day: within 6 weeks of baseline
- fibrates: within 4 weeks of baseline
- lomitapide: within 8 weeks of baseline
- mipomersen: within 24 weeks of baseline
- History of cirrhosis or chronic liver disease based on documented histological evaluation or non-invasive imaging or testing.
- Abnormal liver function tests (LFTs) at screening (AST (Aspartate aminotransferase) or ALT (Alanine aminotransferase) > 2 × upper limit of normal (ULN) and/or Total Bilirubin of > 1.5 × ULN
Where it is running
- Boca Raton location — Boca Raton, Florida, United States
- Kansas City Location — Kansas City, Kansas, United States
- Portland location — Portland, Oregon, United States
- Philadelphia Location — Philadelphia, Pennsylvania, United States
- Nashville location — Nashville, Tennessee, United States
- Montreal location — Montreal, Quebec, Canada
- Palermo location — Palermo, PA, Italy
- Rome location — Roma, RM, Italy
- Rotterdam location — Rotterdam, Netherlands
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.